NEW YORK, May 26 (GenomeWeb News) - GATC Biotech today said it has signed a €2.5-million ($3.2 million) DNA-sequencing contract with the Medical Research Council.

According to the contract, GATC will provide the MRC's 35 sites in the United Kingdom with DNA sequencing services over a period of at least three years in return for about €2.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.